CTD-T AM 6.25/80/5 Tablet
By CTD-T AM
Rx
10 Tablet in a Strip

Composition
Telmisartan(80mg) + Amlodipine(5mg) + Chlorthalidone(6.25mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
July, 2026

liver
CTD-T AM 6.25/80/5 Tablet should be used carefully in individuals with liver disease. It might be necessary to adjust the dosage of CTD-T AM 6.25/80/5 Tablet for such patients. It is strongly advised to consult your doctor before using this medication if you have any liver conditions. Remember, it is not advisable to use CTD-T AM 6.25/80/5 Tablet in individuals with severe liver disease. Your doctor can provide you with the best guidance tailored to your specific liver health needs.

kidney
CTD-T AM 6.25/80/5 Tablet requires caution in severe kidney disease. Consult your doctor for possible dose adjustments as use is not recommended in these cases.

alcohol
It is not recommended to drink alcohol while taking CTD-T AM 6.25/80/5 Tablet. Consult your doctor regarding alcohol consumption with this medication.

driving
Caution - Driving CTD-T AM 6.25/80/5 Tablet may cause side effects like dizziness, headaches, nausea, or tiredness, which could impact driving ability. Be cautious as these effects may affect focus and reaction time while driving.

pregnancy
CTD-T AM 6.25/80/5 Tablet is not safe during pregnancy due to potential risks to the developing baby. In rare life-threatening cases, a doctor might prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
CTD-T AM 6.25/80/5 Tablet is likely safe while breastfeeding. Limited data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹229.15
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024